Chapter 24: Opioid Analgesics, Opioid Antagonist, and Nonopioid Centrally Acting Analgesics Flashcards
analgesics and opioids
Analgesics are drugs that relieve pain without causing the loss of consciousness
Opioids are the most effective pain relievers available
opioid
A general term that is defined as any drug, natural or synthetic, that has actions similar to those of morphine
opiate
A term that applies only to compounds present in opium
endogenous opioid peptides
Three families of peptides:
Enkephalins
Endorphins
Dynorphins
opioid receptors
Three main classes of opioid receptors
Mu receptors: Analgesia, respiratory depression, euphoria, sedation, and physical dependence
Kappa receptors: Analgesia and sedation; kappa activation may underlie psychotomimetic effects seen with certain opioids
Delta receptors
Classification of Drugs That
Act as Opioid Receptors
Agonist, partial agonist, or antagonist:
Pure opioid agonists
Agonist-antagonist opioids
Pure opioid antagonists
Pure Opioid Agonists
Activate mu receptors and kappa receptors
Can produce analgesia, euphoria, sedation, respiratory depression, physical dependence, constipation, and other effects
2 groups: strong and mod-to-strong agonist:
Morphine: Strong opioid agonists and moderate to strong opioid agonists
Codeine: Moderate to strong agonists
Agonist-Antagonist Opioids
Pentazocine, nalbuphine, butorphanol, and buprenorphine
When administered alone, produce analgesia
If administered with a pure opioid agonist, can antagonize analgesia caused by the pure agonist
Pure Opioid Antagonists
Naloxone [Narcan]: Prototype of the pure opioid antagonists
Antagonists at mu and kappa receptors
Do not produce analgesia or any of the other effects caused by opioid agonists
Reversal of respiratory and central nervous system (CNS) depression caused by overdose with opioid agonists
Methylnaltrexone: Used to treat opioid-induced constipation
basic pharm of the opioids
Strong opioid agonists:
Morphine
Other strong opioid agonists
Moderate to strong opioid agonists
Agonist-antagonist opioids
source of morphine
Seedpod of the poppy plant
morphine: overview of pharm actions
Pain relief
Drowsiness
Mental clouding
Anxiety reduction
Sense of well-being
Respiratory depression
Constipation
Urinary retention
Orthostatic hypotension
Emesis
Miosis
Cough suppression
Biliary colic
Tolerance and physical dependence
morphine therapeutic use
Relief of pain -mod to severe. post-op pain, L&D pain, chronic pain caused by cancer and other conditions.
more effective against constant, dull pain than against sharp, intermittent pain. however, sharp pain can be relieved by large doses
Relieves pain without affecting other senses (e.g., sight, touch, smell, and hearing)
No loss of consciousness
Relieves pain by mimicking the actions of endogenous opioid peptides, primarily at mu receptors
sched 2
morphine ADR: resp depression
Infants and the elderly are especially sensitive
Onset:
Intravenous, 7 minutes; intramuscular, 30 minutes; subcutaneous, up to 90 minutes; may persist 4 to 5 hours
Spinal injection: Response may be delayed by hours
PO: 90 min
Tolerance to respiratory depression can develop
Increased depression with concurrent use of other drugs that have CNS depressant actions (e.g., alcohol, barbiturates, and benzodiazepines)
Can compromise patients with impaired pulmonary function
Asthma, emphysema, kyphoscoliosis, chronic cor pulmonale, and extreme obesity
morphine ADR: constipation
Cause: Suppressed propulsive intestinal contractions, intensified nonpropulsive contractions, increased tone of the anal sphincter, and inhibited secretion of fluids into the intestinal lumen
Complications of constipation include fecal impaction, bowel perforation, rectal tearing, and hemorrhoids
Treatment includes physical activity, increased intake of fiber and fluids, stimulant laxatives, stool softeners, and polyethylene glycol
last resort: methylnaltrexone -cant cross BBB so won’t reverse pain relief
morphine ADR: ortho hypotension
Morphine-like drugs lower blood pressure by blunting the baroreceptor reflex and by dilating peripheral arterioles and veins
Patient teaching: Symptoms of hypotension (e.g., lightheadedness and dizziness) and instructions to sit or lie down if they occur
Hypotension can be minimized by moving slowly when changing from a supine or seated position to an upright position
hypotensive medications can exacerbate opioid induced hypotension
morphine ADR: urinary retention and hesitancy
Increases tone in the bladder sphincter
Increases tone in the detrusor muscle, thereby elevating pressure within the bladder and causing a sense of urinary urgency
May interfere with voiding by suppressing awareness of bladder stimuli
encourage pt to void every 4 hr
likely in pt with BPH. anticholinergic meds can exacerbate
morphine ADR: emesis
Promotes nausea and vomiting through the direct stimulation of the chemoreceptor trigger zone of the medulla
Emetic reactions are greatest with the initial dose and then diminish with subsequent doses
Nausea and vomiting are uncommon in recumbent patients but occur in 15% to 40% of ambulatory patients
Nausea and vomiting can be reduced by pretreatment with an antiemetic (e.g., prochlorperazine) and by having the patient remain still
morphine ADR: euphoria/dysphoria
Euphoria: An exaggerated sense of well-being caused by the activation of mu receptors
Dysphoria: A sense of anxiety and unease
Dysphoria is uncommon among patients in pain, but it may occur when morphine is taken in the absence of pain
morphine ADR: sedation
Drowsiness and some mental clouding
Avoid hazardous activities
Sedation can be minimized:
Take smaller doses more often
Use opioids that have short half-lives
Give small doses of a CNS stimulant (e.g., methylphenidate or dextroamphetamine)
Nonamphetamine stimulants such as modafinil [Provigil, Alertec] or armodafinil [Nuvigil] may also be tried
morphine ADR: neurotoxicity
Delirium, agitation, myoclonus, hyperalgesia, and other symptoms
Risk factors include renal impairment, preexisting cognitive impairment, and prolonged high-dose opioid use
Management: Hydration and dose reduction, opioid rotation for long term user is helpful
morphine ADR: tolerance
Tolerance
Increased doses needed to obtain the same response
Develops with analgesia, euphoria, sedation, and respiratory depression
Cross-tolerance to other opioid agonists
No tolerance to miosis or constipation develops
morphine ADR: physical dependence
Abstinence syndrome with abrupt discontinuation
About 10 hours after last dose, the initial reaction occurs and includes yawning, rhinorrhea, and sweating
Progresses to violent sneezing, weakness, nausea, vomiting, diarrhea, abdominal cramps, bone and muscle pain, muscle spasms, and kicking movements
Lasts 7 to 10 days if untreated
Withdrawal is unpleasant but not lethal, as it may be with CNS depressants
morphine pharmakinetics
Administered by several routes: oral, intramuscular, intravenous, subcutaneous, epidural, and intrathecal
Not very lipid-soluble
Does not cross blood-brain barrier easily
Only small fraction of each dose reaches site of analgesic action
morphine precautions
Abuse liability
Use cautiously in pt with:
Decreased respiratory reserve
Pregnancy
Labor and delivery
Head injury
Other precautions
morphine drug interactions
CNS depressants
Anticholinergic drugs
Hypotensive drugs
Monoamine oxidase inhibitors
Agonist-antagonist opioids
Opioid antagonists
Other interactions
morphine toxicity s/sx
Classic triad:
Coma
Respiratory depression -may be as low as 2-4 breath/min
Pinpoint pupils -can dilate secondary to resp depression
morphine tox tx
Ventilatory support
Antagonist: Naloxone [Narcan]